Tag: Outbreak response
-
Africa CDC Statement on Suspected Viral Haemorrhagic Fever in Jinka, Ethiopia
Overview The Africa Centres for Disease Control and Prevention (Africa CDC) is closely monitoring reports of a suspected viral haemorrhagic fever (VHF) in Jinka, located in Ethiopia’s Southern Region. Initial information indicates a potential case has prompted enhanced surveillance and a rapid response by national health authorities, supported by regional and continental partners. What is…
-
Africa CDC Updates on Suspected Viral Haemorrhagic Fever in Jinka, Ethiopia
Overview The Africa Centres for Disease Control and Prevention (Africa CDC) is actively monitoring reports of a suspected viral haemorrhagic fever (VHF) in Jinka, located in the Southern Region of Ethiopia. The notification, received on 12 November 2025, prompted an immediate review by national partners and regional health authorities to ensure rapid risk assessment, timely…
-
Africa CDC Expands Mpox Response with Bavarian Nordic Vaccine Donation
Africa CDC Expands Mpox Response with Bavarian Nordic Vaccine Donation In a continued bid to strengthen Africa’s readiness against mpox, the Africa Centres for Disease Control and Prevention (Africa CDC) has received an additional donation of 110,000 mpox vaccine doses from Bavarian Nordic. The vaccines are allocated to Uganda, one of the countries most affected…
-
Africa CDC Strengthens Mpox Response with Bavarian Nordic Vaccines
Continued Partnership Accelerates Africa’s Mpox Response Africa CDC has received a further boost in its mpox response with an additional donation of 110,000 doses of the MVA-BN mpox vaccine from Bavarian Nordic. The vaccines are allocated to Uganda, one of the countries hardest hit in 2025, through the Mpox Access and Allocation Mechanism (AAM) coordinated…
-
Determinants of mpox vaccination uptake among MSM during the 2022 outbreak: A Lyon, France, single-centre retrospective study
Overview The 2022 mpox outbreak prompted targeted vaccination campaigns for men who have sex with men (MSM) at risk. A large retrospective study from Lyon University Hospital, France, assessed first-dose uptake of the modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine among MSM attending STI and HIV clinics between January 2022 and February 2023. The study categorized…